PIMA542117
Fremanezumab Recombinant Human Monoclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIMA542117-Each-of-1 | In Stock | ₹ 44,020.62 |
PIMA542117 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 44,020.62
GST (18%): ₹ 7,923.712
Total Price: ₹ 51,944.332
Antigen
Fremanezumab
Classification
Recombinant Monoclonal
Conjugate
Unconjugated
Gene Alias
fremanezumab-vfrm; LBR-101; PF-04427429; RI-307; RN-307; TEV-48125
Immunogen
Human CALCA/CALCB
Quantity
100 μg
Primary or Secondary
Primary
Content And Storage
-20° C, Avoid Freeze/Thaw Cycles
Form
Liquid
Target Molecule
Chemical
Applications
ELISA, SDS-Page
Concentration
0.87 mg/mL
Formulation
PBS with no preservative; pH 7.4
Host Species
Human
Purification Method
Protein A
Regulatory Status
RUO
Target Species
Chemical
Product Type
Antibody
Isotype
IgG2 κ
Related Products
Description
- Endotoxin level < 0.01EU/μg by LAL method Use a manual defrost freezer and avoid repeated freeze thaw cycles
- Store at 2 to 8 °C for one week
- Store at -20 to -80 °C for twelve months from the date of receipt
- Fremanezumab is a biosimilar that targets CALCA .
Compare Similar Items
Show Difference
Antigen: Fremanezumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: fremanezumab-vfrm; LBR-101; PF-04427429; RI-307; RN-307; TEV-48125
Immunogen: Human CALCA/CALCB
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 0.87 mg/mL
Formulation: PBS with no preservative; pH 7.4
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG2 κ
Antigen:
Fremanezumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
fremanezumab-vfrm; LBR-101; PF-04427429; RI-307; RN-307; TEV-48125
Immunogen:
Human CALCA/CALCB
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
0.87 mg/mL
Formulation:
PBS with no preservative; pH 7.4
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG2 κ
Antigen: Burosumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: KRN-23; UX-023
Immunogen: Human FGF23
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 1 mg/mL
Formulation: PBS with no preservative; pH 7.4
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG1 κ
Antigen:
Burosumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
KRN-23; UX-023
Immunogen:
Human FGF23
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
1 mg/mL
Formulation:
PBS with no preservative; pH 7.4
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG1 κ
Antigen: Lutikizumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: ABT-981
Immunogen: Human IL1A /IL1B
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 1 mg/mL
Formulation: PBS with no preservative; pH 7.4
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: __
Antigen:
Lutikizumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
ABT-981
Immunogen:
Human IL1A /IL1B
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
1 mg/mL
Formulation:
PBS with no preservative; pH 7.4
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
__
Antigen: Telisotuzumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: ABT-700; hz224G11
Immunogen: Human MET/RCCP2
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA
Concentration: 2.1 mg/mL
Formulation: PBS with no preservative, pH 7.4
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG1 κ
Antigen:
Telisotuzumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
ABT-700; hz224G11
Immunogen:
Human MET/RCCP2
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA
Concentration:
2.1 mg/mL
Formulation:
PBS with no preservative, pH 7.4
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG1 κ